Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients.
Abolghasemi H, Panahi Y, Ahmadinejad M, Toogeh G, Karimi M, Eghbali A, Mirbehbahani NB, Dehdezi BK, Badiee Z, Hoorfar H, Eshghi P, Maghsoudi N, Sahebkar A, Gholami-Fesharaki M.
Abolghasemi H, et al. Among authors: eghbali a.
J Pharmacopuncture. 2018 Jun;21(2):76-81. doi: 10.3831/KPI.2018.21.009. Epub 2018 Jun 30.
J Pharmacopuncture. 2018.
PMID: 30151307
Free PMC article.